脊髓損傷藥物市場：按藥物類型、適應症、應用、給藥途徑、配銷通路和地區

預計2023年，脊髓損傷藥物的全球市場規模將達到74億美元，預測期內（2023-2030年）年複合成長率為5.4%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	74億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	5.40%	2030年市場規模預測	107億美元

圖 1. 2023 年脊髓損傷藥物的全球市場佔有率（%）（按適應症）

脊髓損傷是 31 對脊椎神經的損傷，這些脊椎神經將神經訊號從大腦傳送到身體的各個部位，並控制手臂和腿部的發育。脊髓損傷的基本原因包括損傷、脊髓血液供應喪失、癌症或污染壓迫脊髓。脊髓損傷可以藉助各種方法來確定，例如 X 光、磁混響記錄 (MRI)、圖形斷層掃描 (CT)。製藥業的主要公司都專注於開發與治療脊髓損傷相關的藥物。因此，在市場上引入此類先進產品預計將在預測期內推動全球脊髓損傷治療市場的成長。

市場動態

製藥業的主要公司都致力於開發新藥。因此，在市場上引入此類先進產品預計將在預測期內推動全球脊髓損傷治療市場的成長。例如，2022 年 6 月，完全一體化的基本藥物公司 Amneal Pharmaceuticals, Inc. 獲得美國食品藥物管理局(FDA)核准用於治療與多發性硬化症和其他脊椎疾病相關的痙攣，並宣布 LYVISPAH商業性上市，一種專門的巴氯芬口服顆粒（5、10、20 毫克）產品。

本研究的主要特點

• 本報告對全球脊髓損傷治療藥物市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年度（年複合成長率）。它還強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
• 根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球脊髓損傷藥物市場的主要參與者進行了分析。
• 本研究涵蓋的主要企業包括Teva Pharmaceutical Industries Ltd.、AbbVie Inc.、Pfizer Inc.、Reddy's Laboratories Ltd.、Zydus Cadila、ReNetX Bio, Inc.、InVivo Therapeutics Holdings、Lineage Cell Therapeutics, Inc.、Kringle Pharma, Inc . 、NervGen、Rising Pharmaceuticals、ScieGen Pharmaceuticals、MSN Laboratories Private Limited、Lannett Co Inc.
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 全球脊髓損傷治療藥物市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球脊髓損傷藥物市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 調查目的和假設

• 這項研究的目的
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 市場機會
• 影響分析
• 最近測試啟動
• 流行病學
• 合併、收購和合作
• 法規場景
• 主要進展
• PEST分析

第4章 全球脊髓損傷治療藥物市場-新型冠狀病毒感染疾病（COVID-19）的影響分析

• 經濟影響
• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 對需求和供給的影響

第5章 全球脊髓損傷藥物市場，依藥物類型，2018-2030

• 皮質類固醇
• 肌肉鬆弛劑和抗驚厥藥
• 非類固醇消炎劑(NSAID'S)
• 抗憂鬱症
• 抗驚厥藥
• 其他

第6章 2018-2030 年全球脊髓損傷藥物市場（依適應症）

• 完全性脊髓損傷
• 不完全性脊髓損傷

第7章 2018-2030年全球脊髓損傷藥物市場（依應用）

• 自主神經失衡（AD）
• 痙攣和發炎
• 疼痛管理
• 沮喪

第8章 全球脊髓損傷藥物市場（依給藥途徑），2018-2030 年

• 口服
• 靜脈

第9章 全球脊髓損傷藥物市場，依配銷通路，2018-2030

• 醫院藥房
• 零售藥房
• 網路藥房

第10章 2018-2030年全球脊髓損傷藥物市場（按地區）

• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• GCC
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第11章競爭形勢

• 公司簡介
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

第12章章節

• 參考
• 調查方法

The Global Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.40%	2030 Value Projection:	US$ 10.7 Bn

Figure 1. Global Spinal Cord Injury Therapeutics Market Share (%), By Indication, 2023

Spinal cord wounds are the wounds caused to the 31 sets of spinal nerves, which convey nerve signals from the mind to different parts of the body and likewise control the arm and leg developments. The fundamental driver of spinal cord wounds incorporate injury, loss of blood supply to the spinal cord, and pressure in the spinal cord because of cancer or contamination. Spinal cord wounds can be determined to have the assistance of different methods, for example, X-beam, attractive reverberation record (MRI), and figured tomography (CT). Key players in the pharmaceutical industry are focusing on the development of drugs associated with the treatment of spinal cord injuries. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global spinal cord injury therapeutics market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs for spinal cord injury treatment. Thus, the introduction of such advanced products in the market is expected to drive growth of the global spinal cord injury therapeutics market over the forecast period. For instance, in June 2022, Amneal Pharmaceuticals, Inc., a fully integrated essential medicines company, announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.

Key features of the study:

• This report provides an in-depth analysis of the global spinal cord injury therapeutics market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global spinal cord injury therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Global Spinal Cord Injury Therapeutics Market Detailed Segmentation:

• By Drug Type:
  • Corticosteroids
  • Muscle Relaxants and Anti-spastic drugs
  • Non-steroidal Anti-inflammatory drugs (NSAID'S)
  • Anti-depressants
  • Anticonvulsants
  • Others
• By Indication:
  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury
• By Application:
  • Autonomic Dysreflexia (AD)
  • Spasticity and Inflammation
  • Pain Management
  • Depression
• By Route of Administration:
  • Oral
  • Intravenous
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Indication
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Muscle Relaxants and Anti-spastic Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Non-steroidal Anti-inflammatory Drugs (NSAID'S)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anti-depressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anticonvulsants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Complete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Incomplete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Autonomic Dysreflexia (AD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Spasticity and Inflammation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

12. Section

• References
• Research Methodology
• About us and Sales Contact